Premium
Human immunodeficiency virus lymphomas in the era of antiretrovirals: Is it finally time to change the discussion?
Author(s) -
Gunthel Clifford J.,
Lechowicz Mary Jo
Publication year - 2016
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.30110
Subject(s) - medicine , survivorship curve , human immunodeficiency virus (hiv) , lymphoma , disease , population , cancer , intensive care medicine , health care , immunology , family medicine , environmental health , economics , economic growth
Currently, clinicians involved in the treatment of and research regarding lymphoma may want to look toward achieving the goal of a dual cure of human immunodeficiency virus and cancer in patients with lymphoma. In addition, the difficult issues of health care disparities, disease prevention, and long‐term survivorship need to be addressed in this population. See also pages 2689‐97